Affiris begins clinical testing of Alzheimer’s vaccine - Vienna, 19th July 2007. The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time. This development means that the 8.5 million-Euro venture capital finance agreement the company concluded with Munich-based MIG-Fonds in April 2006 has reached a key milestone on schedule.
International Press Release Publishing for free in 15 languages across 22 countries
Press Releases
Google-Suche:
 

Blog blogger.com

You are not logged in, so we don't know your blog. Please fill in the data to access your blog at blogger.com. The entered information will be stored for this session.
Username
Password
Blog-URL
 
Title of your post
Text of your post
SUBCATEGORIES
Medicine
 
 
Pressreleases by authors
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z